Association between the lengths of GT dinucleotide repeat in the PIK3CA gene with breast cancer risk

被引:2
|
作者
Heshmatpour, Najmeh [1 ]
Hematti, Simin [2 ]
Hejazi, Seyyed Hossein [3 ]
Safari, Forousan [1 ]
Tavassoli, Manoochehr [1 ]
机构
[1] Univ Isfahan, Fac Sci, Dept Biol, Hezar Jarib, Isfahan, Iran
[2] Med Sci Univ Isfahan, Div Oncol, Esfahan, Iran
[3] Isfahan Univ Med Sci, Dept Med Mycol & Parasitol, Esfahan, Iran
关键词
Breast cancer; PIK3CA; GT repeat; Polymorphism; INTRON; PI3K; TRANSCRIPTION; EXPRESSION;
D O I
10.1007/s12032-014-0029-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The phosphatidylinositol 3-kinase (PI3 K)/Akt signaling pathway is one of the most commonly mutated pathways in breast cancer. To date, there has been no study on polymorphism of phosphatidylinositol-3,4-bisphosphonate 3-kinase, catalytic subunit alpha (PIK3CA) gene microsatellites and their link with breast cancer risk. In the present study, we investigate the guanine-thymine (GT) dinucleotide repeat polymorphism in intron 1 of PIK3CA gene in a cohort of 200 breast cancer patients and 200 healthy individuals and its link to the risk of developing breast cancer. The results of this study demonstrate that PIK3CA gene allele distribution in Isfahan population varies between 13 and 20 repeats. GT14 and GT16 were the most common allele present in patients, and GT17 was the most common allele in controls. Women with one or two alleles shorter than 17 GT repeat have a significantly higher risk of developing breast cancer [Odds ratio (OR) 3.6, p = 0.00001 and OR 3.98, p = 0.000001, respectively], in contrast, women with one or two alleles longer than 16 are at lower risk of breast cancer. This result suggests a potential role for this microsatellite as a predictive marker of breast cancer risk in Iranian women.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] PIK3CA mutations in breast cancer: A Tunisian series
    Ben Rekaya, Mariem
    Sassi, Farah
    Saied, Essya
    Kacem, Linda Bel Haj
    Mansouri, Nada
    Zarrouk, Sinda
    Azouz, Saifeddine
    Rammeh, Soumaya
    PLOS ONE, 2023, 18 (05):
  • [22] Analysis of PIK3CA Mutations in Breast Cancer Subtypes
    Arsenic, Ruza
    Lehmann, Annika
    Budczies, Jan
    Koch, Ines
    Prinzler, Judith
    Kleine-Tebbe, Anke
    Schewe, Christiane
    Loibl, Sibylle
    Dietel, Manfred
    Denkert, Carsten
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (01) : 50 - 56
  • [23] PIK3CA alterations in metastatic breast cancer (mBC)
    Albanell, J.
    Casadevall, D.
    Sokol, E. S.
    Albacker, L. A.
    Elvin, J. A.
    Vergilio, J-A.
    Killian, J. K.
    Ngo, N.
    Lin, D.
    Ramkissoon, S.
    Severson, E.
    Ali, S. M.
    Schrock, A. B.
    Chung, J.
    Reddy, P.
    Miller, V. A.
    Alexander, B. M.
    McGregor, K.
    Ross, J. S.
    Leyland-Jones, B.
    ANNALS OF ONCOLOGY, 2019, 30 : 104 - +
  • [24] Characterization of PIK3CA mutations in lobular breast cancer
    Desmedt, C.
    Metzger
    Fumagalli, D.
    Brown, D.
    Singhal, S.
    Vincent, D.
    Adnet, P-Y
    Smeets, D.
    Berthed, F.
    Galant, C.
    Salgado, R.
    Veys, I.
    Saini, K.
    Pruneri, G.
    Krop, I.
    Winer, E.
    Michiels, S.
    Piccart, M.
    Lambrechts, D.
    Larsimont, D.
    Viale, G.
    Sotiriou, C.
    CANCER RESEARCH, 2012, 72
  • [25] Mutation of the PIK3CA gene in anaplastic thyroid cancer
    García-Rostán, G
    Costa, AM
    Pereira-Castro, I
    Salvatore, G
    Hernandez, R
    Hermsem, MJA
    Herrero, A
    Fusco, A
    Cameselle-Teijeiro, J
    Santoro, M
    CANCER RESEARCH, 2005, 65 (22) : 10199 - 10207
  • [26] PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer
    Loi, Sherene
    Michiels, Stefan
    Baselga, Jose
    Bartlett, John M. S.
    Singhal, Sandeep K.
    Sabine, Vicky S.
    Sims, Andrew H.
    Sahmoud, Tarek
    Dixon, J. Michael
    Piccart, Martine J.
    Sotiriou, Christos
    PLOS ONE, 2013, 8 (01):
  • [27] The PIK3CA Gene as a Mutated Target for Cancer Therapy
    Gustin, John P.
    Cosgrove, David P.
    Park, Ben Ho
    CURRENT CANCER DRUG TARGETS, 2008, 8 (08) : 733 - 740
  • [28] Deciphering the Genetic Alterations in PIK3CA Gene Interacting Network and Their Putative Association with Breast Cancer: A Computational Approach
    Dayakar, Sivapriya
    Pandi, Anitha
    Pandi, Chandra
    Arumugam, Paramasivam
    Jayaseelan, Vijayashree Priyadharsini
    MIDDLE EAST JOURNAL OF CANCER, 2025, 16 (01) : 49 - 58
  • [29] PIK3CA in colorectal cancer
    Cathomas, Gieri
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [30] PIK3CA gene mutations in breast carcinoma in Malaysian patients
    Leong, Vincent Ching-Shian
    Jabal, Mohd Faizal
    Leong, Pooi Pooi
    Abdullah, Maizaton Atmadini
    Gul, Yunus Alif
    Seow, Heng Fong
    CANCER GENETICS AND CYTOGENETICS, 2008, 187 (02) : 74 - 79